VLA
Click for more information
0.00% $1.75 viralytics limited

Abstract CT114 withheld due to inclusion in official press program

  1. BoronP
    1,277 Posts.
    lightbulb Created with Sketch. 147
    clock Created with Sketch.
    01/04/17
    07:29
    Post #: 23785614
    CT114 - The MITCI (Phase 1b) study: A novel immunotherapy combination of intralesional Coxsackievirus A21 and systemic ipilimumab in advanced melanoma patients with or without previous immune checkpoint therapy treatment

    CT114: "This abstract has been withheld from publication due to its inclusion in the AACR Annual Meeting 2017 Official Press Program. It will be posted online following its presentation."

    http://www.abstractsonline.com/pp8/#!/4292/presentation/12329

    I can only assume this indicates exceptional results?
    VLA Price at posting: $1.20 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 22  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
3DA To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.